Dr. Holton: We must be advocates for our patients, ourselves
“It's exhausting and it's overwhelming, but traction has been gained and continues to be gained and we are making some meaningful, tangible differences,” says Mara R. Holton, MD.
In this video, Mara R. Holton, MD, discusses the importance of health policy advocacy. Holton is a urologist with AAUrology in Annapolis, Maryland and serves on the LUGPA board of directors.
Transcription:
Mara R. Holton, MD, on the importance of health policy advocacy
I think at our annual meeting, Donna Shalala gave us all a dose of medicine [by] really emphasizing that the system is not great, and it is not perfect, but it is the system that we have, and we are obliged to be advocates for our patients, our peers, our colleagues, and ourselves. And every one of us is going to engage with the health care system, both as a provider and eventually in some capacity as a patient or an advocate for patients. So we're sort of doubly obliged to be involved in these conversations. That said, I understand everyone's fatigue. It's exhausting and it's overwhelming, but traction has been gained and continues to be gained and we are making some meaningful, tangible differences. And absent these efforts, we can certainly anticipate that things will only go backwards.
This transcription has been edited for clarity.
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
First-line pembrolizumab/lenvatinib shows efficacy for advanced non–clear cell RCC
January 29th 2024“Updated efficacy and safety results continue to support pembrolizumab plus lenvatinib as a first-line treatment option for patients with advanced non–clear cell RCC,” lead study author Martin H. Voss, MD.
